Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 4, 1999, Pages 329-334

  Nakada, Mitsutoshi ^a   Yamashita, Junkoh ^a   Okada, Yasunori ^b   Sato, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Astrocytic tumor; Ets 1; Invasion; uPA

Indexed keywords

TRANSCRIPTION FACTOR; UROKINASE;

ARTICLE; ASTROCYTOMA; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLIOMA CELL; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032948303     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199904000-00003     Document Type: Article

References (27)

1. Blasi F. Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 1993; 15:105-11
2. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73:161-95
3. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci 1992;667:1-12
4. Ossowski L, Russo-Payne H, Wilson EL. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res 1991;51: 274-81
5. Yu HR, Schultz RM. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res 1990;50:7623-33
6. Giese A, Westphal M. Glioma invasion in the central nervous system. Neurosurgery 1996;39:235-52
7. Sitrin RG, Gyetko MR, Kole KL, McKeever P, Varani J. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines. Cancer Res 1990; 50:4957-61
8. Nakajima K, Tsuzaki N, Shimojo M, Hamanoue M, Kohsaka S. Microglia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res 1992;577:285-92
9. Landau BJ, Kwaan HC, Verrusio EN, Brem SS. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. Cancer Res 1994; 54:1105-8
10. Yamamoto M, Sawaya R, Mohanam S, et al. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res 1994;54:3656-61
11. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ. Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol 1995;146:1150-60
12. Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R, Rao JS. Prognostic significance of proteolytic enzymes in human brain tumors. J Neurooncol 1994;22:101-10
13. Hsu DW, Efird JT, Hedley-Whyte ET. Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 1995; 147:114-23
14. Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 1996;49:20-37
15. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. Eur J Biochem 1993;211:7-18
16. de Launoit Y, Baert JL, Chotteau A, et al. Structure-function relationships of the PEA3 group of Ets-related transcription factors. Biochem Mol Med 1997;61:127-35
17. Amouyel P, Gegonne A, Delacourte A, Defossez A, Stehelin D. Expression of ETS proto-oncogenes in astrocytes in human cortex. Brain Res 1988;447:149-53
18. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin: Springer-Verlag, 1993
19. Nakada M, Nakamura H, Ikeda E, et al. Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol (in press)
20. Noguchi-Takino M, Endo Y, Yonemura Y, Sasaki T. Relationship between expression of plasminogen activator system and metastatic ability in human cancers. Int J Oncol 1996;8:97-105
21. Collins VP. Cultured human glial and glioma cells. Int Rev Exp Pathol 1983;24:135-202
22. Watabe T, Yoshida K, Shindoh M, et al. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998;77:128-37
23. Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 1993;268:23460-68
24. Delannoy-Courdent A, Mattot V, Fafeur V, et al. The expression of an Ets1 transcription factor lacking its activation domain decreases uPA proteolytic activity and cell motility, and impairs normal tubulogenesis and cancerous scattering in mammary epithelial cells. J Cell Sci 1998;111:1521-34
25. Wernert N, Raes MB, Lassalle P, et al. c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992;140:119-27
26. Matsuzawa K, Fukuyama K, Dirks PB, et al. Expression of stromelysin 1 in human astrocytoma cell lines. J Neurooncol 1996;30: 181-88
27. Uhm JH, Dooley NP, Villemure JO, Yong VW. Glioma invasion in vitro: Regulation by matrix metalloprotease-2 and protein kinase C. Clin Exp Metastasis 1996;14:421-33